Frances K. Heller
Director/Board Member bij MONTEREY INNOVATION ACQUISITION CORP.
Profiel
Frances K.
Heller is the founder of Good2Go, Inc. which was founded in 2015.
She is currently a Co-Chairman at Lava Mae, a Director at Diagnostics for All since 2015, a Director at Affinivax, Inc. since 2014, and an Independent Director at Monterey Innovation Acquisition Corp.
since 2021.
Ms. Heller's former jobs include being a Director at Zafgen, Inc. from 2011 to 2012, an Independent Director at Zafgen, Inc. from 2014 to 2018, a Director at Adimab LLC, a Director at NeuroTherapeutics Pharma, Inc., a Senior Vice President-Business Development at Bristol Myers Squibb Co., a VP-Corporate Development & Legal Affairs at Signature BioScience, Inc. from 2001 to 2003, a Trustee at Dana-Farber Cancer Institute, Inc., an Executive Vice President-Business Development at Exelixis Pharmaceuticals, Inc., a Corporate & Intellectual Property Counsel at Celera Group from 1998 to 2001, a VP-Intellectual Property & Legal Affairs at Zyomyx, Inc., and the Head-Strategic Alliances at Novartis Pharmaceuticals Corp.
from 2003 to 2008 and at Novartis Institutes for Biomedical Research, Inc. from 2003 to 2008.
She was also a Trustee at Bristol-Myers Squibb Foundation from 2012 to 2014.
Ms. Heller's education includes a graduate degree from American University, an undergraduate degree from Tulane University (Louisiana), and a graduate degree from Golden Gate University School of Law.
Actieve functies van Frances K. Heller
| Bedrijven | Functie | Begin |
|---|---|---|
| MONTEREY INNOVATION ACQUISITION CORP. | Director/Board Member | 30-09-2021 |
Lava Mae
 Lava Mae Services to the Health IndustryHealth Services Lava Mae is a non-profit company that focuses on expanding hygiene and sanitation access worldwide. The company is based in San Francisco, CA. The company works to recruit, mentor, and train grassroots projects to achieve this goal. | Chairman | - |
Good2Go, Inc.
 Good2Go, Inc. Packaged SoftwareTechnology Services Good2Go, Inc. provides touchless and virtual queuing solutions for merchants through their enterprise software platform. The private company is based in San Francisco, CA. The company's solutions are completely keyless and touchless, creating a much-improved experience for staff and customers. The company was founded by Frances K. Heller and Frances K. Heller has been the CEO since incorporation. | Chief Executive Officer | 01-01-2015 |
Affinivax, Inc.
 Affinivax, Inc. BiotechnologyHealth Technology Affinivax, Inc. operates as a biotechnology company which develops novel conjugation technology. The company is headquartered in North Cambridge, MA. | Director/Board Member | 30-10-2014 |
| Diagnostics for All | Director/Board Member | 26-01-2015 |
Eerdere bekende functies van Frances K. Heller
| Bedrijven | Functie | Einde |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Director/Board Member | 06-06-2018 |
| Exelixis Pharmaceuticals, Inc. | Corporate Officer/Principal | 29-12-2016 |
| California State Bar Association | Corporate Officer/Principal | 15-05-2014 |
| Bristol-Myers Squibb Foundation | Director/Board Member | 01-01-2014 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Opleiding van Frances K. Heller
| American University | Graduate Degree |
| Tulane University (Louisiana) | Undergraduate Degree |
| Golden Gate University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Bedrijven in privébezit | 17 |
|---|---|
Signature BioScience, Inc.
 Signature BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Signature BioScience, Inc. discovers new drugs by applying its parallel target and compound selection process. The private company is based in Hayward, CA and has subsidiaries in the United States. The company was founded by Andrew Peter Sandham and John Hefti. | Commercial Services |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
Adimab LLC
 Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Health Technology |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
| Exelixis Pharmaceuticals, Inc. | Health Technology |
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |
Zyomyx, Inc.
 Zyomyx, Inc. Medical SpecialtiesHealth Technology Zyomyx, Inc. manufactured point-of-care diagnostic devices based on cell-counting technology. It engaged in the development and commercialization of diagnostic platforms. The firm offered disposable CD4 T-cell, a point-of-care test for HIV and AIDS treatment. The company was founded by Peter Wagner, Steffen Nock, Christian Itin, and Dana Ault-Riche in 1998 and was headquartered in Fremont, CA. | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| California State Bar Association | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| Bristol-Myers Squibb Foundation | |
NeuroTherapeutics Pharma, Inc.
 NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapeutics Pharma, Inc. is a biopharmaceutical company focused on developing therapies for diseases associated with central nervous system hyper-excitability. It is developing compounds that decrease or eliminate aberrant excitatory discharges by working through a new mechanism of action. The firm's proprietary molecules target a novel molecular site that will create a pipeline of potential new treatments for multiple CNS disorders. The company's lead compound, NTP-2014, has exhibited excellent efficacy results in multiple preclinical models of epilepsy, acute and neuropathic pain. NeuroTherapeutics Pharma was founded in 2006 and is headquartered in Chicago, IL. | Health Technology |
| Diagnostics for All | |
Affinivax, Inc.
Affinivax, Inc. BiotechnologyHealth Technology Affinivax, Inc. operates as a biotechnology company which develops novel conjugation technology. The company is headquartered in North Cambridge, MA. | Health Technology |
Good2Go, Inc.
Good2Go, Inc. Packaged SoftwareTechnology Services Good2Go, Inc. provides touchless and virtual queuing solutions for merchants through their enterprise software platform. The private company is based in San Francisco, CA. The company's solutions are completely keyless and touchless, creating a much-improved experience for staff and customers. The company was founded by Frances K. Heller and Frances K. Heller has been the CEO since incorporation. | Technology Services |
Monterey Innovation Acquisition Corp.
 Monterey Innovation Acquisition Corp. Financial ConglomeratesFinance Monterey Innovation Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 23, 2020 and is headquartered in New York, NY. | Finance |
Lava Mae
Lava Mae Services to the Health IndustryHealth Services Lava Mae is a non-profit company that focuses on expanding hygiene and sanitation access worldwide. The company is based in San Francisco, CA. The company works to recruit, mentor, and train grassroots projects to achieve this goal. | Health Services |
